10/31
09:52 am
etnb
89BIO (NASDAQ:ETNB) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Neutral
Report
89BIO (NASDAQ:ETNB) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
10/22
06:57 am
etnb
89BIO (NASDAQ:ETNB) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Neutral
Report
89BIO (NASDAQ:ETNB) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
10/16
04:58 pm
etnb
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
Low
Report
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
10/8
11:22 am
etnb
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
Low
Report
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
10/6
05:10 pm
etnb
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
Low
Report
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
10/2
02:05 am
etnb
89BIO (NASDAQ:ETNB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
89BIO (NASDAQ:ETNB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/1
04:51 pm
etnb
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash [Yahoo! Finance]
Low
Report
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash [Yahoo! Finance]
9/30
12:44 pm
etnb
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal [Yahoo! Finance]
Low
Report
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal [Yahoo! Finance]
9/29
02:38 pm
etnb
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders
9/23
08:08 pm
etnb
5 Biotech Stocks Worth Adding to Your Portfolio Now [Yahoo! Finance]
Low
Report
5 Biotech Stocks Worth Adding to Your Portfolio Now [Yahoo! Finance]
9/23
05:30 pm
etnb
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB)
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB)
9/23
02:00 pm
etnb
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, GTLS, PGRE, ETNB on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, GTLS, PGRE, ETNB on Behalf of Shareholders
9/19
12:24 pm
etnb
89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
Low
Report
89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
9/19
10:59 am
etnb
89BIO (NASDAQ:ETNB) was downgraded by analysts at Raymond James Financial, Inc. from a "strong-buy" rating to a "market perform" rating.
Low
Report
89BIO (NASDAQ:ETNB) was downgraded by analysts at Raymond James Financial, Inc. from a "strong-buy" rating to a "market perform" rating.
9/19
08:55 am
etnb
89Bio (ETNB) Soars 86 Percent to Historic High on $3.5-Billion Roche Merger [Yahoo! Finance]
Low
Report
89Bio (ETNB) Soars 86 Percent to Historic High on $3.5-Billion Roche Merger [Yahoo! Finance]
9/19
08:07 am
etnb
89BIO (NASDAQ:ETNB) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $14.50 price target on the stock.
Low
Report
89BIO (NASDAQ:ETNB) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $14.50 price target on the stock.
9/19
08:07 am
etnb
89BIO (NASDAQ:ETNB) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.
Low
Report
89BIO (NASDAQ:ETNB) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.
9/18
07:02 am
etnb
ETNB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 89bio, Inc. Is Fair to Shareholders
Low
Report
ETNB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 89bio, Inc. Is Fair to Shareholders
9/18
03:02 am
etnb
Shareholder Alert: The Ademi Firm Investigates Whether 89bio, Inc. is Obtaining a Fair Price for its Public Shareholders
High
Report
Shareholder Alert: The Ademi Firm Investigates Whether 89bio, Inc. is Obtaining a Fair Price for its Public Shareholders
9/18
01:21 am
etnb
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH [Yahoo! Finance]
Low
Report
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH [Yahoo! Finance]
9/18
01:02 am
etnb
89bio, Inc. Announces Agreement to be Acquired by Roche
High
Report
89bio, Inc. Announces Agreement to be Acquired by Roche
9/16
01:31 am
etnb
89BIO (NASDAQ:ETNB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
89BIO (NASDAQ:ETNB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/5
04:17 pm
etnb
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
9/5
04:05 pm
etnb
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)